- Olaparib Combined with an ATR or Chk1 Inhibitor as a Treatment Strategy for Acquired Olaparib-Resistant BRCA1 Mutant Ovarian Cells.
- Burgess BT, Anderson AM, McCorkle JR, Wu J, Ueland FR, Kolesar JM.
- Diagnostics (Basel). 2020 Feb 22;10(2). pii: E121. doi: 10.3390/diagnostics10020121.
- PMID: 32098452
- PubMed abstract
- Source abstract